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Background: Pregnant women living with HIV infection (PWLWH) have elevated rates of
preterm birth (PTB) in which HIV and cART are implicated. PWLWH also have a high
prevalence of adverse vaginal microbiota, which associate with genital tract inflammation.
The mechanism underlying PTB in PWLWH is unknown. We present the first data in
PWLWH on genital-tract matrix-metalloproteinase-9(MMP-9), an important collagenase
implicated in labour onset, and tissue inhibitor of metalloproteinases-1(TIMP-1) and
explore correlations with local inflammation and vaginal bacteria.
Material and Methods: Cervical vaginal fluid (CVF) collected by a soft cup and high
vaginal swabs (HVS) were obtained from PWLWH and HIV uninfected pregnant women
(HUPW) at three antenatal time points. Maternal characteristics, combination antiretroviral
therapy (cART) exposure, and pregnancy outcome were recorded. Concentrations of
MMP-9, TIMP-1 and ten cytokines were measured by immunoassays. Vaginal microbiota
composition was determined through 16S rRNA amplicon sequencing. MMP-9, TIMP-1
and cytokine concentrations were compared by HIV status, cART, and prematurity and in
PWLWH correlations with polymorphonuclear leucocytes, cytokines and bacterial genera
were explored.
Results: CVF was available for 50 PWLWH (108 samples) and 12 HUPW (20 samples)
between gestation weeks 14-38. Thirty-six PWLWH conceived on cART and 14 initiated
post-conception. There were five and one PTB outcomes in PWLWH and HUPW
respectively. PWLWH had higher mean CVF concentrations of MMP-9 (p<0.001) and
TIMP-1 (p=0.035) in the second trimester compared with HUPWwith a similar trend in thegy | www.frontiersin.org November 2021 | Volume 11 | Article 7501031
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Frontiers in Cellular and Infection Microbiolothird trimester. PWLWH also had higher CVF values of cytokines: IL-1b, IL-8, IL-12 and
TNF-a in both trimesters compared to HUPW (p ≤ 0.003). In PWLWH, MMP-9 positively
correlated with TIMP-1 (r=0.31, p=0.002) and CVF polymorphonuclear leucocytes
(r=0.57, p=0.02). Correlations were observed between MMP-9 and three cytokines: IL-
1b (r=0.61), IL-8 (r=0.57) and TNF-a (r=0.64), p<0.001, similarly for TIMP-1. Abundance
of anaerobic pathobionts correlated with MMP-9: Gardnerella (r=0.44, p<0.001),
Atopobium (r=0.33, p=0.005), and Prevotella genera (r=0.39, p<0.001). Conversely
proportion of Lactobacillus genera negatively correlated with MMP-9 (rho=-0.46,
p<0.001). MMP-9/TIMP-1 ratio increased with gestational age at sampling in PWLWH,
but this was no longer significant after adjusting for confounders and no difference by
prematurity was observed in this sub-study.
Conclusions: Here we show strong correlations of MMP-9 to genital tract inflammation
and sub-optimal bacterial genera in PWLWH indicating the ascending genital tract
infection pathway may be a contributory mechanism to the high risk of PTB.Keywords: HIV - human immunodeficiency virus, preterm (birth), metalloproteinase, microbiome and dysbiosis,
Gardnerella speciesINTRODUCTION
Pregnant women living with HIV infection (PWLWH) are
disproportionately affected by PTB outcomes, with some
cohorts experiencing two to four-fold the risk observed in the
general population (Thorne et al., 2004; Short and Taylor, 2014;
Wedi et al., 2016). The aetiology of this phenomenon is unclear
but the successful use of combination antiretroviral therapy
(cART) to prevent mother to child transmission of HIV
(PMTCT) has not had the same impact on high rates of PTB
and may increase risk of this complication (Thorne et al., 2004).
Literature around this obstetric complication in PWLWH
suggest that it is the result of a complex interplay of high
background risk factors for PTB e.g. African and Caribbean
ethnicity (Tuomala et al., 2005; Li et al., 2019), anaemia (Chen
et al., 2012), low body mass index (BMI) (Young et al., 2012),
hypertension (Chen et al . , 2012) and pre-eclampsia
(Wimalasundera et al., 2002), cART exposure (class of third drug
e.g. protease inhibitors and timing in relation to conception) (C
Short and Taylor, 2014) and infection factors. The latter include
advancedHIVdisease (Slykeret al., 2014;Wedi et al., 2016; Favarato
et al., 2018), intercurrent co-infections with bacterial vaginosis
(Taha, 1999; Slyker et al., 2014), sexual transmitted infections
(Slyker et al., 2014; Shava et al., 2019), other pathogens e.g.
cytomegalovirus, malaria (McDonald et al., 2019; Moraka et al.,
2019), and higher risk and severity of chorioamnionitis
(Goldenberg et al., 2006; Ategeka et al., 2019; Obimbo et al., 2019).
Preterm birth in the general population is an umbrella
syndrome with multiple aetiologies (Goldenberg et al., 2008).
Ascending genital tract infection is thought to be a significant
factor in premature rupture of membranes (Brown et al., 2018)
and spontaneous preterm labour (Elovitz et al., 2019) and
potentially impair placentation, all effected through changes in
maternal immune surveillance and tolerance (Mor et al., 2017).
The pathologic mechanism of PTB in PWLWH is unclear. Wegy | www.frontiersin.org 2hypothesize the elevated risk of PTB is the result of an
inflammatory process driven by alternations in: the balance of
cytokines at the maternal foetal interface (Fiore et al., 2006; Short
and Taylor, 2014; Short et al., 2021) and dysregulation of
immune activation of maternal T cells (Short et al., 2017) to
promote local immune cell infiltration in the female reproductive
tract; both of which are influenced by local vaginal microbiota
composition (Short et al., 2013; Anahtar et al., 2015; Short
et al., 2021).
We and others have described that PWLWH in European and
African settings have a microbiota either dominated by
Lactobacillus iners or with a diverse anaerobic bacteria
community structure (Price et al., 2019; Gudza-Mugabe et al.,
2020; Short et al., 2021). Lactobacillus single species dominance in
pregnancy, particularly L. crispatus, is associated with term birth
outcomes whereas L. iners species dominance, the least stable
Lactobacillus community structure, and mixed anaerobes are
associated with PTB (Kindinger et al., 2017; Brown et al., 2018;
Elovitz et al., 2019; Fettweis et al., 2019). Within our London HIV
PTB study cohort all PTB occurred in women with these adverse
vaginal microbiota groups (Short et al., 2021). How these bacteria
exert their effects on downstream pathways to trigger labour is not
fully elucidated. Pilot data from our group exploring differentially
expressed cervicovaginal immune proteins by HIV status using
proteomic profiler arrays indicated thatmatrixmetalloproteinase 9
(MMP-9), extracellular matrix metalloproteinase protein inducer
(EMMPRIN) and neutrophil gelatinase B-associated lipocalin
(NGAL) were significantly upregulated compared to HIV
uninfected pregnant women (HUPW) (Short, 2019).
MMP-9 (also known as gelatinase B) is a zinc dependent
endopeptidase involved in extracellular matrix (ECM)
remodelling of type IV collagen (and to lesser extent type V)
and elastin that is part of several physiological processes
including uteroplacental re-modelling in reproduction, cell
migration (particularly neutrophils), angiogenesis and woundNovember 2021 | Volume 11 | Article 750103
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upregulated in membrane rupture, placental detachment and
myometrial contractility in term and preterm labour (Weiss
et al., 2007; Sundrani et al., 2012; Ulrich et al., 2019). MMP-9
expression occurs in multiple cell types, many of which are found
at the maternal-foetal interface although the source of MMP-9 in
the events leading to labour is not fully understood. Its
expression is thought to be regulated by cytokines: IL-1b, IL-8,
IL-10 and TNF-a, prostaglandins (Peltier, 2003; Padron et al.,
2020), and tissue inhibitor metalloproteinase-1 (TIMP-1)
(Juanjuan Chen and Khalil, 2017). Much of the available data
on MMP-9 in pregnancy are derived from plasma and amniotic
fluid samples, tissue explants, cell lines and rat models with
minimal data on the cervical and lower genital compartments
(Choi et al., 2009; Becher et al., 2010). Human data exist on the
relationship between MMP-9 and intra-amniotic infection but
the direct relationship with vaginal microbiota as the source are
scant (Locksmith et al., 2001; Kindinger et al., 2016; Padron et al.,
2020) and non-existent in PWLWH.
Here we exploreMMP-9, TIMP-1 and cytokine concentrations,
and local polymorphonuclear leucocytes in a subgroup of PWLWH
from the London HIV PTB study for whom cervicovaginal fluid
(CVF) and high vaginal bacterial metataxonomic data were
available and examine the association with lower genital tract
microbiota composition. The full characterization of the vaginal
microbiota of PWLWH from the LondonHIV Preterm birth study
has been described previously (Short et al., 2021). These data have
been used for correlation analyses with CVFMMP-9, TIMP-1 and
cytokine concentrations.METHODS
Study Design and Setting
The London HIV PTB study has been described previously
(Short et al., 2021). PWLWH and HUPW were prospectively
recruited between 2013-2017 at eleven tertiary care hospitals
across London. The study was approved by the NHS Health
Research Authority National Research Ethics Service (NRES)
(Ref 13/LO/0107). The London HIV PTB study is an exploratory
hypothesis generating pilot study and thus no sample size
calculation has been performed. This is a sub-analysis of the
main study of the group of women who provided lower female
genital tract (FGT) samples.
Participants and Sample Collection
Exclusion criteria were: <18 years old, inability to give written
informed consent, current injecting drug use, multiple gestation
pregnancy and in vitro fertilization. All women not previously
known to be living with HIV infection underwent routine
antenatal screening with fourth generation combined HIV
antibody and p24 antigen tests and syphilis serology in the first
trimester. For PWLWH screening for gonorrhea and chlamydial
infection was routinely offered as per national guidelines.
Gestational age was determined by obstetric ultrasound at 10-
14 weeks. Maternal demographics were recorded and for
PWLWH: ART regimen, timing of cART exposure in relationFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3to conception and immunovirological parameters were also
documented. Gestational age at delivery, mode of delivery and
any obstetric complications were recorded. Preterm birth was
defined as delivery <37 completed weeks gestation.
Participants were invited to undergo lower FGT sampling at
three time points across the second and third trimesters: 14.0-
21.9 weeks; 22.0-27.9 weeks; 28.0-38.0 weeks. Clinician or self-
taken high vaginal swab [HVS (BBL ™ CultureSwab™ MaxV
Liquid amies swab)] and paired menstrual soft cup (Instead®,
Evofem Ltd™) samples were obtained. Soft cups were retained
for a minimum offive minutes prior to removal. All FGT samples
were kept on ice and stored at -80°C within two hours of
collection until further processing.
Quantification of CVF MMP-9, TIMP-1,
Cytokines and Polymorphonuclear
Leucocytes
CVF was thawed and extracted from the soft cup as previously
described (Short et al., 2018) and diluted in an extraction buffer
containing a protease inhibitor cocktail (Castle et al., 2004) in a
dynamic range to fall within the standard curve of the intended
assay. ELISA assays (Human Quantikine®, R and D Systems™)
were used to measure concentrations of MMP-9 and TIMP-1
according to manufacturer’s instructions (dilution range 40-800-
fold). Multiplex chemiluminescent assays [V-plex Human Pro-
inflammatory cytokine panel, Meso Scale Discovery™ (MSD)]
were used to measure concentrations of ten cytokines: IFN-g, IL-
1b, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-a
according to the manufacturer’s instructions (dilution range 4-
100-fold). All samples were run in duplicate. The inter-plate
coefficient of variance (CV) value provided by the manufacturer
was 8% for MMP-9, 4% for TIMP-1 (R and D Systems™) and for
the cytokine multiplex plates the CV is typically <10% (MSD™).
An intra-plate CV cut off ≤15% was used as the limit of
acceptable variation between duplicates for these analyses.
Light microscopy was performed on 19 samples from
PWLWH for whom a paired dry HVS was available to grade
polymorphonuclear leucocyte count by ordinal scale: 0, 1–5, 6–
10, 11–20, 21–30, and 31+ per high-powered field over an
average of 3 fields.
DNA Extraction and 16S rRNA Gene
Sequencing (Metataxonomics)
For PWLWH bacterial DNA was extracted from the HVS using a
combination of enzymatic digestion and mechanical disruption of
cell membranes and the QIAamp® DNA Mini kit (Qiagen™), as
previously described (MacIntyre et al., 2015). The V1-V2
hypervariable regions of the 16S rRNA gene were amplified with
a fusion primer set that includes four different 28F primers chosen
to improve detection of Bifidobacteriales and a 388R primer(24).
The 28F-YM forward primer (5′-GAGTTTGATCNTGGCTCAG-
3′) was mixed in a ratio of 4:1:1:1 with 28F Borrellia (5’-GAGTTT
GATCCTGGCTTAG-3’), 28F Chloroflex (5′-GAATTTGA
TCTTGGTTCAG-3’) and 28F Bifido (5’-GGGTTCGATTCTGG
CTCAG-3’) (RTL Genomics Amplicon Diversity Assay List). The
forward primers included an Illumina i5 adapter (5′-AATGAT
ACGGCGACCACCGAGATCTACAC-3′), an 8-base-pair (bp)November 2021 | Volume 11 | Article 750103
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388R reverse primer (5′-TGCTGCCTCCCGTAGGAGT-3′) was
constructed with an Illumina i7 adapter (5′-CAAGCAGAAGAC
GGCATACGAGAT-3′), an 8-bp bar code, a primer pad (reverse,
5′-AGTCAGTCAG- 3′). The pair end multiplex sequencing was
performed on an Illumina MiSeq™ platform (Illumina® Inc.) at
Research and Testing Laboratory (Lubbock, TX, USA).
Sequence Analysis
The MiSeq SOP pipeline and software package Mothur were
used to analyse RNA sequence data. Highly similar amplicons
were clustered into operational taxonomic units (OTUs) using
the kmer searching method and the Silva bacterial database
(www.arb-silva.de/). All OTUs had a taxonomic cut-off
of ≥97%. Classification was performed using the Ribosomal
Database Project (RDP) reference sequence files and the Wang
method (Wang et al., 2007). The RDP MultiClassifier script was
used for determination of OTUs (phylum to genus) and species
level taxonomies were determined using USEARCH (Edgar,
2010). To account for potential bias introduced by differences
in sequence depth, samples were rarefied to the smallest OTU
read count (n= 7738) and proportion of total reads calculated for
each sample to generate species level abundance.
Statistical Analyses
Cross-Sectional 2nd and 3rd Trimester Comparison
by HIV Status
CVF from 50 PWLWH and 12 HUPW were available for cross-
sectional analyses, each participant contributed one sample per
trimester group. Maternal demographics were compared by
Welch, Mann-Whitney U and Fisher Exact tests according to
variable type, data distribution, variance, and group size. Mean
MMP-9, TIMP-1, MMP-9/TIMP-1 ratio and cytokine
concentrations were compared in a cross-section of second
trimester (PWLWH n=47, HUPW n=10) and third trimester
samples (PWLWH n=33, HUPW n= 9) by HIV status and cART
exposure using Welch tests and ANOVA.
Longitudinal Analyses in PWLWH
Using longitudinal data from PWLWH alone (108 samples)
associations of polymorphonuclear leucocyte count, cytokine
concentrations and bacterial genera abundance with MMP-9,
TIMP-1 concentrations and their ratio were explored initially by
Spearman’s correlation and then partial correlation, adjusting for
maternal age, race and BMI. To identify potential indirect effects
between MMP-9, TIMP-1 and bacterial genera abundance, key
cytokines were then included in partial correlation as covariates
to test if the associations changed. A Bonferroni adjustment of
p=0.01 was used as the threshold of significance to account for
multiple comparison. To retain sensitivity p-values > 0.01 < 0.05
were considered as a trend.
Significant correlations were then characterised by hierarchical
multiple linear regression adjusting for confounders, with patient
ID included as a random effect and predictors inputted as second
factors. Predictedmodels of the inter-relationship betweenMMP-9,
TIMP-1 with key bacterial species and cytokines were postulated
from regression results.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4Mediation analyses were used to investigate whether the
predicted relationship between Gardnerella and Lactobacillus
genera and MMP-9 was mediated by indirect effects of key
inflammatory cytokines or TIMP-1 [PROCESS macro, Model
4, version 4.0 (Preacher and Hayes, 2008)]. The 95%
bootstrapped confidence interval for indirect effects is based on
1000 samples and considered significant if the bootstrapped
confidence intervals did not cross zero. All analyses were
performed in statistical software package, SPSS (version 27;
IBM, Armonk NY, USA).RESULTS
Study Participants Characteristics
PWLWH and HUPW were of similar age (median 35 and 33
years respectively), see Table 1. The predominant race of
PWLWH was Black (82%) whereas Caucasian race was the
most common in HUPW (58%). PWLWH had higher median
body-mass index (BMI) and lower CD4 cell counts than HUPW.
There was no difference in gestational age at delivery and
proportion of women delivering prematurely between
PWLWH and HUPW in this sub-analysis (5 (10%) and 1
(8%), p=0.68), see Table 1.
cART Exposure in PWLWH
Thirty-six (72%) PWLWH conceived on cART and 14 initiated
cART post conception (27%). cART comprised a backbone of
two nucleoside analogue reverse transcriptase inhibitors and one
of the following third agents: a Protease Inhibitor (PI) n = 17
(34%); a Non-Nucleoside Reverse Transcriptase Inhibitor
(NNRTI) n = 20 (40%); an Integrase Strand Transfer Inhibitor
(INSTI) n = 10 (20%) and a third NRTI n = 3 (6%).
Cross-Sectional Analyses of CVF MMP-9,
TIMP-1, and Cytokines in the Second and
Third Trimester by HIV Status
CVF MMP-9, TIMP-1 and Pro-Inflammatory Cytokine
Concentrations Are Higher in PWLWH Than HUPW
PWLWH had a higher mean concentration of MMP-9 in the
second and third trimesters, although this did not reach
significance in the third trimester (4 fold higher, p<0.001 and
1.5 fold, p=0.213 respectively), see Table 2. PWLWH had a
higher mean concentration of TIMP-1 in the second and third
trimesters (12 fold higher, p=0.035 and 3 fold higher, p=0.044
respectively). There was no statistical difference observed in
MMP-9/TIMP-1 ratio by HIV status in the second and third
trimester but a non-statistical trend towards an increase in ratio
between second and third trimesters for PWLWH (1.7 fold
higher, p=0.276) but not HUPW was observed, see Table 2.
PWLWH had higher concentrations of most measured CVF
cytokines in the cross-section of second and third trimester
samples, see Supplementary Figures 1A, B. The CVF
cytokines with the most marked difference by HIV status in
both trimesters were: IL-1b (19-22 fold higher, 2nd p=0.002, 3rd
p=0.003); IL-8 (13-16-fold higher, 2nd p<0.001, 3rd p<0.001); IL-November 2021 | Volume 11 | Article 750103
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fold higher, 2nd p<0.001, 3rd p=0.002), see Table 3.
CVF MMP-9, TIMP-1 and Pro-Inflammatory Cytokine
Concentrations in PWLWH Do Not Differ by cART
Exposure or Pre-Term Birth
In PWLWH no statistical differences in CVF MMP-9, TIMP-1
concentration or MMP-9/TIMP-1 ratio were observed by cART
timing or class of the third drug, see Supplementary Figure 2.
CVF cytokines: IL-1b, IL-8, IL-12 and TNF-a concentrations in
PWLWH did not differ by cART timing or class of third ART
drug, see Supplementary Figures 3A, B. There was no difference
in MMP-9, TIMP-1 or CVF cytokines: IL-1b, IL-8, IL-12 and
TNF-a by prematurity in either second or third trimesters, see
Supplementary Tables 1, 2.
Longitudinal Analyses in PWLWH
CVF MMP-9 Positively Correlates With TIMP-1,
Polymorphonuclear Leucocytes, Pro-Inflammatory
Cytokines and Vaginal Pathobiont Abundance in PWLWH
In PWLWH CVF MMP-9 positively correlated with
polymorphonuclear leucocyte count (r=0.57, n=19, p=0.02), see
Figure 1A, and TIMP-1 concentration (r=0.31, n=108, p=0.002),
after adjusting for maternal age, BMI and ethnicity, see
Figure 1B. There was no statistical correlation of MMP-9 with
gestational age at sampling (r=0.008, n=108, p=0.935).
MMP-9 positively correlated with IL-1b (r=0.61, n=91,
p<0.001), IL-8 (r=0.57, n-91, p<0.001) and TNF-a (r=0.64, n=91,
p<0.001), after adjusting for maternal age, BMI and ethnicity, see
Figure 2A. Mean abundance of adverse anaerobic pathobionts alsoFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5correlated positively with MMP-9 (p ≤ 0.005): Gardnerella
(r=0.44, n=77, p<0.001), Atopobium (r=0.33, n=77, p=0.005), and
Prevotella genera (r=0.39, n=77, p<0.001), see Figure 2B.
Conversely mean proportion of Lactobacillus genera negatively
correlated with MMP-9 (r= -0.46, n=77, p<0.001).
When partial correlation was controlled for cytokine IL-1b the
associations between MMP-9 and key bacterial genera abundance
were no longer significant (Gardnerella: r=0.10, p=0.433;Atopobium:
r=0.15, p=0.225; Prevotella: r=-0.11, p=0.358 and Lactobacillus: r=-
0.13, p=0.285).Whenpartial correlationwas controlled for IL-8 there
was a lowering of the correlation efficient with Gardnerella (r=0.37,
p=0.002) and Lactobacillus genera (r=-0.36, p<0.001) but the
associations retained significance, the association with Atopobium
(r=0.29, p=0.016) or Prevotella (r=0.23, p=0.056) were lost. When
partial correlationwas controlled for TNF-a there was a reduction of
the correlation efficient with Lactobacillus (r=-0.26, p=0.034),
Gardnerella (r=0.20, p=0.106), Atopobium (r=0.21, p=0.088) and
Prevotella genera (r=0.23, p=0.057).
CVF TIMP-1 Positively Correlates With Pro-
Inflammatory Cytokines and Vaginal Pathobiont
Abundance in PWLWH
In PWLWH TIMP-1 positively correlated with IL-1b (r=0.59,
n=91, p<0.001), IL-6 (r=0.31, n=91, p=0.004), IL-8 (r=0.30,
n=91, p=0.005) and TNF-a (r=0.42, n=91, p<0.001) after
controlling for maternal age, BMI and ethnicity, see
Figure 3A. Mean abundance of adverse anaerobic pathobionts
correlated positively with TIMP-1 (p<0.02): Gardnerella (r=0.51,
n=77, p<0.001), Atopobium (r=0.56, n=77, p<0.001) and
Prevotella (r=0.29, n=77, p=0.015), after controlling forTABLE 2 | Mean MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio in second and third trimesters by HIV status.
Group 2nd trim MMP-9 ng/
mL
3rd trim MMP-9 ng/
mL
2nd trim TIMP-1 ng/
mL






PWLWH 2823 (1740-3906) 3289 (2074-4490) 230 (36-425) 135 (68-172) 114 (45-183) 437 (-172-1046
HUPW 767 (308-1225) 2241 (980-3502) 20 (2-37) 54 (6-102) 201 (-117-519) 190 (-49-429)
P value <0.001 0.207 0.035 0.044 0.561 0.439November 2021 |Second trimester analyses: PWLWH n=47, HUPW=10; Third trimester analyses: PWLWH n=33, HUPW= 9. Protein concentrations are given as geometric mean (95%CI).TABLE 1 | Maternal Demographics by HIV status.
Characteristic PWLWH n=50 HUPW =12 P value
Age/years
[Median (range)] 35 (21-45) 33 (20-43) 0.205
Ethnicity [n (%)] <0.001
Caucasian 4 (10) 7 (58)
Black 41 (82) 3 (25)
Other 5 (8) 2 (18)
BMI [Median (IQR)] 25 (22-30) 23 (20-25) 0.032
Baseline CD4 +/cells/mm3 [Median (IQR)] 620 (433-724) 970 (900-1390) <0.001
Gestational age at delivery/weeks [Median (IQR)] 39 (38-40) 40 (38-41) 0.512
Birth outcome [n (%)]
Term 42 27 0.682
Preterm 5 1
Missing 3 1
Birth weight/grams [Median (IQR)] 3190 (2908-3375) 3100 (2800-3200) 0.456Volume 11 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?maternal age, BMI and ethnicity, see Figure 3B. Conversely,
mean proportion of Lactobacillus genera negatively correlated
with TIMP-1 (r=-0.61, n=77, p<0.001). There was no statistical
correlation of TIMP-1 with polymorphonuclear leucocytes (r=-0.23,
n=19, p=0.400) or gestational age at sampling (r=-0.15,
n=108, p=0.146).
When partial correlation between TIMP-1 and key bacterial
genera abundance was controlled for cytokine IL-1b, there was a
substantial reduction in associations (Gardnerella: r=0.23, p=0.058;
Atopobium: r=0.46, p<0.001; Prevotella: r=-0.03, p=0.829 and
Lactobacillus: r=-0.39, p=0.001). When partial correlation was
controlled for IL-8 there was minimal change of the correlationFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6efficient with Gardnerella (r=0.47, p<0.001), Atopobium (r=0.54,
p<0.001) and Lactobacillus genera (r=-0.57, p<0.001) but the
association with Prevotella was lost (r=0.20, p=0.109). When
partial correlation was controlled for TNF-a there was a
moderate reduction of the correlation efficient with Gardnerella
(r=0.39, p=0.001), Atopobium (r=0.51, p<0.001), Prevotella genera
(r=0.16, p=0.187) and Lactobacillus (r=-0.52, p<0.001).
When TIMP-1 was included in partial correlation between
MMP-9 and bacterial abundance, the strength of the correlation
co-efficients were lowered, some of which retained significance
(Gardnerella: r=0.35, p=0.003; Atopobium: r=0.20, p=0.096;
Prevotella: r=0.34, p=004 and Lactobacillus: r=-0.36, p=0.002).TABLE 3 | Mean IL-1b, IL-8, IL-12 and TNF-a in second and third trimesters by HIV status.
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63 (43-83) 124 (82-165) 291 (175-406) 493 (205-781)
HUPW 458 (81-836) 846 (62-1630) 6065 (-82-12213) 6819 (523-13115) 7 (-7-21) 15 (-16-47) 19 (-19-57) 18 (-15-51)
P value 0.002 0.003 <0.001 <0.001 <0.001 <0.001 <0.001 0.002November 2021 | Volume 1Second trimester analyses: PWLWH n=47, HUPW=10; Third trimester analyses: PWLWH n=33, HUPW= 9. Protein concentrations are given as geometric mean (95%CI).A
B
FIGURE 1 | (A) Scatter graphs to explore correlation of CVF MMP-9 concentrations with high vaginal polymorphonuclear leucocyte counts in PWLWH; (B) Scatter
graph to explore correlation between CVF MMP-9 and TIMP-1 concentrations in PWLWH. r = correlation co-efficient, controlled for maternal age, BMI and ethnicity.1 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?CVF MMP-9/TIMP-1 Ratio Positively Correlates With
Abundance of Vaginal Lactobacillus Genera and
Negatively Correlates With Gardnerella Genera and
Pro-Inflammatory Cytokines in PWLWH
There was a negative association between MMP-9/TIMP-1 ratio
and IL-1b (r=-0.22, n=91, p=0.044) and TNF-a (r=-0.20, n=91,
p=0.076), after controlling for maternal age, BMI and ethnicity in
PWLWH, see Figure 4A. There was also a trend towards aFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7negative correlation between MMP-9/TIMP-1 ratio with relative
abundance of Gardnerella genera (r=-0.28, p=0.02), and a
positive association with Lactobacillus genera (r=0.31, p=0.01),
see Figure 4B.
Spearman’s correlation showed MMP-9/TIMP-1 ratio was
positively associated with polymorphonuclear leucocyte count
(rho=0.49, n=19 p=0.02) and gestational age at sampling
(rho=0.27, n=108, p=0.004), see Figure 5A, B. The significanceA
B
FIGURE 2 | (A) Scatter graphs to explore correlation of CVF MMP-9 concentrations with key CVF cytokine concentrations. I. IL-1b; II. IL-8; III. TNF-a. (B) Scatter
graphs to explore correlation of CVF MMP-9 concentrations with proportions of key vaginal bacterial genera. I. Gardnerella; II. Atopobium; III. Prevotella; IV.
Lactobacillus. r = correlation co-efficient, controlled for maternal age, BMI and ethnicity.November 2021 | Volume 11 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?of these correlations were lost after controlling for maternal age,
BMI and ethnicity: polymorphonuclear leucocyte count (r=0.36,
n=19, p=0.184) and gestational age at sampling (r=0.005,
n=108, p=0.603).
Modelling of the Relationship Between
Vaginal Bacteria, Cytokines, TIMP-1 and
MMP-9 in PWLWH
To explore the relationship between MMP-9, TIMP-1, bacterial
genera and IL-1b, hierarchical multiple linear regression was
performed. The first step of the model was adjusted for potential
confounders: maternal age, ethnicity and BMI, with patient ID
included as a random effect and MMP-9, TIMP-1, IL-1b,
Gardnerella and Lactobacillus genera abundance inputted as a
second factors. In step one maternal age, ethnicity and BMIFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8explained 5% of the variance in CVF MMP-9 concentration.
After entry of predictor variables the total variance of the model
as a whole was 47%, F (8, 64) =7.02, p<0.001. In the final model,
only two measures were statistically significant with IL-1b
recording a higher beta value (b=0.68, p<0.001) than TIMP-1
(b=-0.29, p=0.039).
Based on the significant associations identified in the
preceding analyses, four models of mediation between vaginal
bacterial genera and MMP-9 with indirect effect of IL-1b
mediation and TIMP-1 mediation were proposed, see Figure 6
and 7. There was a significant indirect effect of vaginal
Gardnerella abundance on CVF MMP-9 concentration through
IL-1b consistent with mediation, b=0.31 BCa CI [0.19-0.43], see
Figure 6. There was a significant indirect effect of vaginal
Lactobacillus abundance on CVF MMP-9 concentrationA
B
FIGURE 3 | (A) Scatter graphs to explore correlation of CVF MMP-9 concentrations with key CVF cytokine concentrations. I. IL-1b; II. IL-6; III. IL-8; IV.TNF-a. (B)
Scatter graphs to explore correlation of CVF MMP-9 concentrations with proportions of key vaginal bacterial genera. I. Gardnerella; II. Atopobium; III. Prevotella; IV.
Lactobacillus. r = correlation co-efficient, controlled for maternal age, BMI and ethnicity.November 2021 | Volume 11 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?through IL-1b consistent with mediation, b=-0.35 BCa CI [-0.48-
-0.23]. When exploring mediation of TIMP-1, there was no
significant indirect effect on the relationship between either
Gardnerella or Lactobacillus on MMP-9 concentrations,
see Figure 7.DISCUSSION
The main findings of these exploratory analyses include that
PWLWH have high CVF concentrations of MMP-9, TIMP-1,
pro-inflammatory cytokines and MMP-9/TIMP-1 ratios in
comparison to the HUPW participants. In PWLWH, MMP-9
and TIMP-1 were highly correlated and MMP-9/TIMP-1 ratio
increased with gestational age at sampling. CVF MMP-9 and
TIMP-1 concentrations strongly correlated with vaginal
proportions of anaerobic genera: Gardnerella; Atopobium and
Prevotella and key inflammatory cytokines: IL-1b, IL-8 and
TNF-a. Higher vaginal abundance of Lactobacillus genera
associated with lower MMP-9 concentrations. Both MMP-9
and MMP-9/TIMP-1 ratio positively correlated with vaginal
polymorphonuclear leucocyte counts. Exploration of indirect
effects between MMP-9, Gardnerella and Lactobacillus genera
and IL-1b indicate full mediation suggesting the association
between vaginal bacterial and this interstitial collagenase are
likely to be driven by changes in expression of this key pro-
inflammatory cytokine. TIMP-1 was not shown to mediate the
relationship between bacteria and MMP-9 in these data. Within
this sub-analysis of PWLWH and HUPW who donated CVF to
the HIV PTB study, there was no difference in expression ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9MMP-9 or TIMP-1 by prematurity, but numbers were small and
unlikely to be powered to show such a difference.
The concentration of MMP-9 observed in the lower FGT of
PWLWH in both second and third trimesters was much higher
than previously published values of expression in serum of
HUPW (Sorokin et al., 2010; Tency et al., 2012; Chen and
Khalil, 2017), amniotic fluid of labouring and non-labouring
HUPW [(Maymon et al., 2000; Locksmith et al., 2001, (Maymon
et al., 2000; Locksmith et al., 2001; Myntti et al., 2017)] and the
cervical mucous from HUPW (Becher et al., 2010). Becher and
colleagues explored the expression of MMP-9, TIMP-1 and IL-8
in the cervical mucous plug (CMP) in pregnancy and found that
MMP-9 and IL-8 expression was greatest at the distal portion of
the CMP closest to the vagina (Becher et al., 2010). They also
demonstrated that MMP-9, IL-8 but not TIMP-1 concentrations
increased from early to late pregnancy and were higher in
women labouring preterm compared to term. MMP-9 and
TIMP-1 concentrations in our analyses of HUPW were 200
and 2-fold higher in the second trimester than those observed in
CMP by Becher and colleagues in early pregnancy, with a
positive CVF MMP-9/TIMP-1 ratio compared to an inverse
ratio observed in Becher’s CMP samples. This is likely to be
the result of an addition vaginal source of MMP-9 and
differences in sample handling including the use of protease
inhibitors. In addition, Becher and colleagues did not show a
relationship between MMP-9 and vaginal bacteria but
considered a limited number of pathobionts using less sensitive
culture methods.
MMP-9 is known to be expressed bymany cells at the maternal
foetal interface including: neutrophils; macrophages; NK cells;A
B
FIGURE 4 | (A) Scatter graphs to explore correlation of CVF MMP-9/TIMP-1 ratio with I. IL-1b; II.TNF-a in PWLWH; (B) Scatter graph to show the association
between CVF MMP-9/TIMP-1 ratio and I. Gardnerella genera; II. Lactobacillus genera in PWLWH. r = correlation co-efficient, controlled for maternal age, BMI
and ethnicity.November 2021 | Volume 11 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?vascular endothelial cells of the decidua; cervical fibroblasts and
epithelial cells (Lockwood et al., 2008; Naruse et al., 2009; Gonzalez
et al., 2011; Ulrich et al., 2019). Gonzalez and colleagues
demonstrated that in PTB macrophages are the main source of
MMP-9 at the cervix, whereas MMP-9 production at term is non-
leucocyte dependant (Gonzalez et al., 2011). We hypothesise that
neutrophils andmacrophages are thepredominant sourceofMMP-
9 in the lower FGT of PWLWH and MMP-9 expression in the
cervical environment is elevated as a result of an inflammatory
response to vaginal microbiota composition, supported by the
observed associations with polymorphonuclear leucocytes.
Further in-depth modelling of the relationship with local innate
immune cells in this cohort was limited by the small numbers for
which matched vaginal polymorphonuclear leucocyte counts
were available.
MMP-9 concentrations in CVF increase with cervical
ripening at term (Choi et al., 2009) and are proposed to enable
cervical effacement and dilatation through remodelling of the
ECM (Peltier, 2003; Challis et al., 2009). In addition to its ECM
effects, MMP-9 has a role processing other molecules including
inflammatory cytokines with a demonstrated role in term and
preterm labour: IL-8 and IL-1b. The correlations observed in
these data between key inflammatory cytokines and MMP-9 mayFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10be the result of MMP-9 cleavage of these chemokines and
cytokines or as a result of upregulation by downstream
signalling of the innate immune response to vaginal
pathobionts or both. The reciprocal upregulation observed in
TIMP-1 may be the result of positive feedback and homeostatic
regulation. TIMP-1 upregulation was not directly proportional
to that seen with MMP-9 and hence there was an increase in
MMP-9/TIMP-1 ratio across gestation, which could result in a
balance that favours collagen IV degradation in ECM.
These analyses are the first to demonstrate the association
between vaginal anaerobes, inflammation, and ECM remodelling
proteases in PWLWH and adds to the body of evidence for an
ascending infection model of PTB with a vaginal source and
associated inflammatory response at the cervix, lowering the
threshold for early initiation of labour. It must be borne in mind
that associations do not imply causality andHIV-associated PTB is
likelymulti-factorial, including a role of cARTwhichmaymodulate
some of these pathways. HIV Protease Inhibitors, the most
implicated class of antiretrovirals, are purported to not affect
extracellular proteases but could potentially affect inhibitory
protein activity. No demonstrable difference in expression of
MMP-9 and TIMP-1 was observed by class of third agent in this
small samplewhichmaybe the result of type 2 error. cARTmay alsoA
B
FIGURE 5 | (A) Scatter graphs to explore correlation of CVF MMP-9/TIMP-1 ratio with polymorphonuclear leucocyte counts in PWLWH; (B) Scatter graph to show
the association between CVF MMP-9/TIMP-1 ratio and gestational age at sampling in PWLWH ⍴ = rho.November 2021 | Volume 11 | Article 750103
Short et al. MMP-9, Inflammation and Pathobionts Underlying HIV-PTB?
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11exert its effects directly on the vaginal microbiota (Ray et al., 2021).
Genetic polymorphismsmay also explain the elevated expression of
MMP-9, 82% of whom were of Black race (Pereza et al., 2014;
Pandey and Awasthi, 2020). The racial heterogeneity of this cohort
may bias conclusions comparing by HIV status however analyses
within PWLWHwere adjusted for ethnicity and remain valid. The
ethnicity of the PWLWH cohort reflect the women receiving
antenatal care in the UK, many of whom are African and
Caribbean migrants and may be generalisable to women in other
settings, given the majority of PWLWH reside in Africa
(Unaids.org, 2018). The findings of this study would ideally be
replicated in a larger cohort, powered to look at differences by
prematurity and includeraciallymatchedcontrols.The role of racial
disparity inPTBrisk is in itself an importantquestionand is likely to
be the result of many interplaying factors including: prejudice,
genetics, socioeconomics, healthcare access and stress influencing
downstream factors such as background co-morbidities,
neuroendocrine, infection, microbiota, and immune mediators
(Braveman et al., 2021).
Altered angiogenesis at implantation and placentation has been
postulated as amechanismunderlyingHIVassociatedPTBand low
birth weight (Conroy et al., 2017). MMP-9 is a key regulator of this
process in normal pregnancy and dysregulated expression has been
implicated in both pre-eclampsia and IUGR (Juanjuan Merchant
et al., 2004; Świerczewski et al., 2012;ChenandKhalil, 2017;Ardiani
et al., 2019), the former of whichwas rarely seen in PWLWH in the
pre cART era (Wimalasundera et al., 2002). More recently a case
control study inCamerooncomparedMMP-9expression inplasma
collected from the placental intervillous space by HIV status and
found no difference in expression between groups suggesting any
differences in MMP-9 in PWLWH are unlikely to be placental in
origin (Esemu et al., 2019).
Within these sub-analyses we did not show any difference in
gestational age at delivery or expressionofCVFMMP-9 andTIMP-
1 by prematurity. The small sample size reduces power to observe
these differences in PTB rates, which were seen in the main HIV
PTB study cohort (Short, 2019; Short et al., 2021). There was
however a moderate association between MMP-9/TIMP-1 ratio
with gestational age that warrants further exploration and
validation in a larger group, ideally with matched controls
and exploring other network proteins such as EMMPRIN and
Lipocalin-2, the transcriptome and presence of local immune cells.
In conclusion, we have shown vaginal anaerobes and key pro-
inflammatory cytokines positively correlate with ECM modifying
protease MMP-9 and its inhibitory protein TIMP-1 in PWLWH,
the ratio of which increase in pregnancy and may result in cervical
remodelling as one mechanism underlying HIV-associated PTB.DATA AVAILABILITY STATEMENT
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